Modern therapies against PC include androgen-deprivation therapy (ADT) and the treatment with antiandrogens as blockers of the AR pathway [54,55]; however, after a few months to up to few years of treatment, tumours become castration-resistant and do not respond to antiandrogens therapy. This evidence concerns the gene AR and pachyonychia congenita.